Pharmaceutical composition for inhibiting HIV protease
US5484801A · kind A · utility
91Cited by
9References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 12, 1995 |
| Grant date | Jan 16, 1996 |
| Priority date | — |
| Expiry date | May 12, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D277/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition is disclosed which comprises a solution of an HIV protease inhibiting compound in a pharmaceutically acceptable organic solvent comprising a mixture of (1) (a) a solvent selected from propylene glycol and polyethylene glycol or (b) a solvent selected from polyoxyethyleneglycerol triricinoleate, polyethylene glycol 40 hydrogenated castor oil, fractionated coconut oil, polyoxyethylene (20) sorbitan monooleate and 2-(2-ethoxyethoxy)ethanol or (c) a mixture thereof and (2) ethanol or propylene glycol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.